Hydromer(R) Medical Coating on LATECBA's Endoprostheses Delivery Systems for Use With Their Abdominal Aortic Aneurysm Treatme...
June 13 2013 - 4:21PM
Marketwired
Hydromer, Inc. (OTC Pink: HYDI) and LATECBA S.A., an Argentinean
company, have entered into a Supply and Support Agreement.
Under the terms of this agreement, LATECBA is licensed to use
the proprietary Hydromer® hydrophilic coatings on LATECBA's
balloon-expandable Endoprostheses delivery systems used with their
Abdominal Aortic Aneurysm treatment device.
The Hydromer medical coatings are very lubricious and slippery,
reduce friction, improve and ease delivery of LATECBA's catheters
through the difficult vascular pathways.
In addition, Hydromer® has unique properties to maintain
lubricity and durability while significantly reducing particulates,
and remain in compliance with the stringent USP#788 low
particulates in blood standards.
"We are very excited and pleased that our Hydromer coating was
selected for use with Latecba's innovative balloon-expandable
Endoprostheses delivery systems which is used with their Abdominal
Aortic Aneurysms treatment device," commented Martin von Dyck,
Executive Vice President of Hydromer, Inc., adding, "We are
delighted with our new relationship which is the cornerstone of our
new South American medical device coatings initiative."
About Hydromer, Inc.: Hydromer, Inc. is a
bio-technology-based company involved in the research and
development, manufacture, contract coating and commercialization of
specialized polymer and hydrogel products for medical device,
animal health, cosmetic, personal care, and industrial uses. These
technologies include Hydromer lubricious / anti-microbial /
anti-thrombogenic / cell anti-mitosis / cell growth enhancing
coatings for the medical marketplace.
About LATECBA S.A.: LATECBA S.A is an
enterprise which has been developing for the last fourteen years in
the area of biomedical products. Its commitment is to satisfy its
customers with the highest levels of quality in all products.
Founded in 1994, in Buenos Aires, it originally focused on the
development and manufacture of the SETA family of endoprostheses to
treat vascular diseases.
Hydromer ® is a registered trademark of Hydromer, Inc.
Contact: Martin von Dyck Executive Vice President For additional
information please visit the following Web-sites: www.hydromer.com
www.latecba.com -OR- P: 908.722.5000 sales@hyrdomer.com
Hydromer (CE) (USOTC:HYDI)
Historical Stock Chart
From Jul 2024 to Aug 2024
Hydromer (CE) (USOTC:HYDI)
Historical Stock Chart
From Aug 2023 to Aug 2024